NCT05331339

Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)

Effectiveness in Real Life of the Insulia® Digital Tool in Patients with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 68 (actual)
• Sponsor: Centre Hospitalier Sud Francilien · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to evaluate the INSULIA digital tool (automation of basal insulin dose calculation in type 2 diabetes) within the framework of a French national telemedicine experimentation program (ETAPES) in a single-center study. The assumption is that a better metabolic control with this tool.

Detailed description

Basal insulin titration in people with type 2 diabetes is of major importance to obtain the optimal dose to regulate fasting blood glucose without hypoglycemia. Significant inertia in treatment optimization has been observed among both general practitioners and diabetologists. The INSULIA tool (automation of basal insulin dose calculation in type 2 diabetes) within the framework of a French national telemedicine experimentation program (ETAPES) has been supported by the health authorities. The data collected are of a single-center cohort of adult patients with type 2 diabetes who used this tool between 2018 and 2021. It is supposed that a better metabolic control with this tool and aimed to understand factors associated with better results.

Conditions

• Type 2 Diabetes Mellitus

Timeline

• Start date: 2022-11-02
• Primary completion: 2022-12-02
• Completion: 2022-12-02
• First posted: 2022-04-15
• Last updated: 2024-11-26

Locations

1 site across 1 country: France